The RestoreLeak Consortium obtain a dedicated 3-year funding from the European Union through the 2021 call of the ERA-NET NEURON program on “Neurodevelopmental Disorders” .

22 November 2021 This consortium among several institutions aiming at accelerating the development of effective therapies for the ultrarare CLIFAHDD and IHPRF Syndromes, (NALCN/UNC80 gene mutations)- The RestoreLeak consortium, led…

Continue Reading The RestoreLeak Consortium obtain a dedicated 3-year funding from the European Union through the 2021 call of the ERA-NET NEURON program on “Neurodevelopmental Disorders” .

NALCN – UNC80 Research advances CLIFAHDD and IHPRF Syndrome

Fundación Libellas. September 2020. Newsletter. https:fundacionlibellas.org Our understanding of the NALCN protein complex responsible for the CLIFAHDD and IHPRF1&2 syndromes has reached new milestones over the last months. Two recent…

Continue Reading NALCN – UNC80 Research advances CLIFAHDD and IHPRF Syndrome

The RestoreLeak Consortium obtain a dedicated 3-year funding from the European Union through the 2021 call of the ERA-NET NEURON program on “Neurodevelopmental Disorders” .

22 November 2021 This consortium among several institutions aiming at accelerating the development of effective therapies for the ultrarare CLIFAHDD and IHPRF Syndromes, (NALCN/UNC80 gene mutations)- The RestoreLeak consortium, led…

Continue Reading The RestoreLeak Consortium obtain a dedicated 3-year funding from the European Union through the 2021 call of the ERA-NET NEURON program on “Neurodevelopmental Disorders” .